CDC Advisers Recommend FluMist for Kids
WASHINGTON (Reuters) - MedImmune's FluMist nasal vaccine should be included in the U.S. government's Vaccines for Children program, expanding its distribution to children over the age of 5 and teens, federal advisers said on Thursday.
MedImmune said the Advisory Committee on Immunization Practices meeting in Atlanta had expanded its recommendations on FluMist to include children and adolescents aged 5 to 18 for the 2004-05 season. The vaccine, a weakened version of the influenza virus dripped into the nose, was previously recommended for healthy adults aged 18 to 50.
Article from Reuters Health